These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1359109)
1. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. Winter JC; Rabin RA J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109 [TBL] [Abstract][Full Text] [Related]
2. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
3. Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats. Filip M; Przegaliński E Pol J Pharmacol; 1996; 48(4):397-402. PubMed ID: 9112679 [TBL] [Abstract][Full Text] [Related]
4. Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin. Winter JC; Rabin RA Pharmacol Biochem Behav; 1993 Apr; 44(4):851-5. PubMed ID: 8385783 [TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences. Kleven MS; Koek W J Pharmacol Exp Ther; 1998 Jan; 284(1):238-49. PubMed ID: 9435184 [TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870 [TBL] [Abstract][Full Text] [Related]
8. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF; Lesourd M; Mocaer E; Koolhaas JM J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850 [TBL] [Abstract][Full Text] [Related]
9. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors. Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623 [TBL] [Abstract][Full Text] [Related]
10. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575 [TBL] [Abstract][Full Text] [Related]
11. Urapidil analogues are potent ligands of the 5-HT1A receptor. Gross G; Schüttler K; Xin X; Hanft G J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491 [TBL] [Abstract][Full Text] [Related]
12. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat. Schreiber R; de Vry J J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807 [TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord. Bervoets K; Millan MJ J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554 [TBL] [Abstract][Full Text] [Related]
14. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin. Rabin RA; Winter JC Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905 [TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555 [TBL] [Abstract][Full Text] [Related]
16. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist. Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541 [TBL] [Abstract][Full Text] [Related]
17. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine. Winter JC Pharmacol Biochem Behav; 1988 Jan; 29(1):193-5. PubMed ID: 2895479 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide. Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of idazoxan on forskolin-stimulated adenylate cyclase activity through 5-hydroxytryptamine1A receptors. Kawai N; Yamamoto T; Baba A; Yamamoto H; Moroji T Arzneimittelforschung; 1994 Jan; 44(1):1-3. PubMed ID: 7907870 [TBL] [Abstract][Full Text] [Related]
20. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs]. Uchitomi Y; Yamawaki S Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]